YLT-11
YLT-11 is a potent, selective and orally active PLK4 inhibitor with Kd values of >10000, 653, >10000, 5.2 nM for PLK1, PLK2, PLK3, PLK4, respectively. YLT-11 shows antiproliferative activity. YLT-11 induces Apoptosis and cell cycle arrest at G2/M phase. YLT-11 show anticancer activity.
For research use only. We do not sell to patients.
- CAS No.: 3040940-49-3
- Formula: C24H24N6O
- Molecular Weight:412.49
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
Biological Activity
|
PLK4 5.2 nM (Kd) |
PLK2 653 nM (Kd) |
PLK1 >10000 nM (Kd) |
PLK3 >10000 nM (Kd) |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| Breast carcinoma cell | IC50 |
60 nM
Compound: 12; YLT-11
|
Antiproliferative activity against human TNBC cells assessed as reduction in cell viability
Antiproliferative activity against human TNBC cells assessed as reduction in cell viability
|
[PMID: 38199166] |
YLT-11 (0-1 µM; 48 h) decreases the expression of p-PLK4 in a dose-dependent manner[1].
YLT-11 (0-0.5 µM; 0-48 h) induces apoptosis and cell cycle arrest at G2/M phase[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:MDA-MB-231, MDA-MB-468, BT549, MCF-7 cells
-
Concentration:0-10 µM
-
Incubation Time:24-96 h
-
Result:Showed antiproliferative activity in a time-dependent and concentration-dependent manner with IC50s of 120, 68, 73, 74 nM for MDA-MB-231, MDA-MB-468, BT549, MCF-7 cells, respectively.
-
Cell Line:MDA-MB-468, MDA-MB-231 cells
-
Concentration:0, 0.25, 0.5, 1 µM
-
Incubation Time:48 h
-
Result:Decreased the expression of p-PLK4 in a dose-dependent manner.
-
Cell Line:MDA-MB-468, MDA-MB-231 cells
-
Concentration:0.25 µM
-
Incubation Time:0-48 h
-
Result:Induced cell cycle arrest at G2/M phase.
-
Cell Line:MDA-MB-468, MDA-MB-231 cells
-
Concentration:0, 0.125, 0.25, 0.5 µM
-
Incubation Time:24, 48 h
-
Result:Induced apoptosis of cancer cells in a time-dependent and concentration-dependent manner with the expression of cleaved caspase-3 and cleaved PARP1 increased.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Six-week-old female BALB/c nude mice[1]
-
Dosage:30, 90 mg/kg
-
Administration:P.o.; daily for 20 days
-
Result:Remarkably inhibited the growth of tumor xenografts in a dose-dependent manner.
Chemical Information
-
CAS No. 3040940-49-3
-
Molecular Weight 412.49
-
Formula C24H24N6O
-
SMILES
CC(NC1=NC=CC(C2=CC3=C(C=C2)C(/C=C/C4=CC=C(CN(C)C)C=C4)=NN3)=N1)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Powered by Bioz